Ustekinumab: cutaneous disorders, malignancies, infections
Prescrire International 24(156): 17
2015
ISSN/ISBN: 1167-7422 PMID: 25729825 Document Number: 683560
Document emailed within 1 workday
Related Documents
Hamazaki, H.; Hasegawa, H.; Horiuchi, A.; Teshima, H.; Hiraoka, A.; Masaoka, T.; Nasu, K.; Uchino, H.; Tatsumi, N.; Inoue, N.; Kageyama, T.; Kawagoe, H.; Tukaguchi, M.; Hukuhara, S.; Takahashi, T.; Takatsuka, H.; Kanamaru, A.; Kakishita, E.; Nagai, K.; Hara, H.; Kanayama, Y.; Sugiyama, H.; Kitani, T. 1997: Clinical evaluation of cefpirome sulfate for severe infections in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infections Japanese Journal of Antibiotics 50(1): 12-21Mohanty, P.; Mohanty, L.; Devi, B.P. 2001: Multiple cutaneous malignancies in xeroderma pigmentosum Indian Journal of Dermatology Venereology and Leprology 67(2): 96-97
Williams, J.Z.; Evans, G.R.; Ainslie, N.B. 1998: Cutaneous nasal malignancies: is primary reconstruction safe? Texas Medicine 94(8): 57-61
Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861
Wejroch, M-P.; Cornillet, P.; Perceau, G.; Durlach, A.; Bernard, P. 2004: Frequency of associated malignancies in cutaneous lymphomas: a retrospective study of 86 cases Annales de Dermatologie et de Venereologie 131(4): 339-345
Catalano, P.J.; Sen, C.; Biller, H.F. 1995: Cranial neuropathy secondary to perineural spread of cutaneous malignancies American Journal of Otology 16(6): 772-777
Hamazaki, H.; Horiuchi, A.; Hasegawa, H.; Masaoka, T.; Kitani, T.; Kanayama, Y.; Sugiyama, H.; Tatsumi, N.; Kageyama, T.; Uchino, H. 1994: Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. the Hanshin Study Group of Hematopoietic Disorders and Infections Japanese Journal of Antibiotics 47(6): 763-770
Sperling, L.C. 1992: Mohs surgery and the reconstructive surgeon: the interdisciplinary approach for treating difficult cutaneous malignancies of the head and neck Ear Nose and Throat Journal 71(4): 189-190; 193-195
Campbell, K. 1996: An analysis of blood malignancies and disorders Nursing Times 92(13): 36-37
Khodakova, I.A. 2014: Adjustment disorders in children, first hospitalized for hematological malignancies Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(9): 4-8
Feuilhade, M.; Bazex, J.; Claudy, A.; Roujeau, J.C. 2002: Bacterial and fungal cutaneous/mucous infections. Dermatophyte infections of glabrous skin, skinfolds, and skin appendages Annales de Dermatologie et de Venereologie 129(10 Suppl): S58-S64
Pagano, L.; Caira, M.; Candoni, A.; Offidani, M.; Fianchi, L.; Martino, B.; Pastore, D.; Picardi, M.; Bonini, A.; Chierichini, A.; Fanci, R.; Caramatti, C.; Invernizzi, R.; Mattei, D.; Mitra, M.Enza.; Melillo, L.; Aversa, F.; Van Lint, M.Teresa.; Falcucci, P.; Valentini, C.Giovanna.; Girmenia, C.; Nosari, A. 2006: The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study Haematologica 91(8): 1068-1075
Ueda, T.; Masaoka, T.; Shibata, H.; Namiuchi, S.; Sonoda, T.; Takubo, T.; Nakamura, H.; Yoshitake, J.; Ishigami, S. 1980: Intravenous administration of amikacin sulfate for the severe infections complicated with hematologic malignancies Japanese Journal of Antibiotics 33(11): 1166-1170
Madhavan, T. 1984: Bacterial infections in the compromised host with special emphasis on patients with hematologic malignancies Comprehensive Therapy 10(1): 19-24
Hutas, G. 2008: Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies Current Opinion in Investigational Drugs 9(11): 1206-1215
Manfredi, R.; Calza, L. 2009: Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy Recenti Progressi in Medicina 100(12): 547-549
Shimazaki, C.; Inaba, T.; Murakami, S.; Oku, N.; Itoh, K.; Ura, Y.; Nakagawa, M.; Fujita, N. 1990: Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies Japanese Journal of Antibiotics 43(8): 1402-1406
Kudsk, K.A. 1992: Occult gastrointestinal malignancies producing metastatic Clostridium septicum infections in diabetic patients Surgery 112(4): 765
Pagano, L.; Girmenia, C.; Mele, L.; Ricci, P.; Tosti, M.E.; Nosari, A.; Buelli, M.; Picardi, M.; Allione, B.; Corvatta, L.; D'Antonio, D.; Montillo, M.; Melillo, L.; Chierichini, A.; Cenacchi, A.; Tonso, A.; Cudillo, L.; Candoni, A.; Savignano, C.; Bonini, A.; Martino, P.; Del Favero, A. 2001: Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program Haematologica 86(8): 862-870
Tarle, S.F.; Souza Nascimento, R.A.; Lins Alencar, N.J. 1985: Tratamento tópico das infecções cutâneas com fusidato de sódio a 2% - Traitement topique des infections cutanées par le fusidate de sodium à 2% - Topical treatment of cutaneous infections with 2% sodium fusidate Anais Brasileiros de Dermatologia 60(3): 149-153